Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP

Diabetes mellitus is one of the most common chronic health conditions worldwide, requiring effective and long-term management to maintain healthy blood sugar levels. Combination therapy has become a preferred treatment option for many patients with Type 2 Diabetes Mellitus due to its enhanced efficacy and patient convenience.

Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP

Curavax Pharmaceuticals Pvt. Ltd. proudly offers Gliminift M2, a high-quality anti-diabetic medication containing Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP. This combination medicine helps achieve better glycemic control by targeting multiple mechanisms involved in blood sugar regulation.

Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP

Product Details

Brand Name: Gliminift M2
Generic Name: Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP
Therapeutic Category: Anti-Diabetic Medicine
Manufacturer: Curavax Pharmaceuticals Pvt. Ltd.

Composition

Each tablet of Gliminift M2 contains:

  • Glimepiride IP – 2 mg
  • Metformin Hydrochloride IP (Prolonged Release) – 500 mg

This dual-action combination is recommended for patients with Type 2 Diabetes Mellitus who require improved blood sugar control beyond diet, exercise, and monotherapy.

What is Gliminift M2?

Gliminift M2 is an oral anti-diabetic medication specifically designed for the treatment of Type 2 Diabetes Mellitus. It combines two proven medicines that work together to regulate blood glucose levels effectively.

  • Glimepiride stimulates the pancreas to release insulin.
  • Metformin Prolonged Release reduces glucose production in the liver and improves insulin sensitivity.

How Does Gliminift M2 Work?

1. Glimepiride

Glimepiride belongs to the sulfonylurea class of medicines. It works by:

  • Stimulating pancreatic beta cells to release insulin
  • Improving glucose utilization
  • Helping maintain healthy blood sugar levels

2. Metformin Hydrochloride Prolonged Release

Metformin belongs to the biguanide class and works by:

  • Reducing glucose production in the liver
  • Increasing insulin sensitivity
  • Reducing intestinal absorption of glucose
  • Providing sustained blood sugar control through prolonged-release technology

Together, these ingredients provide comprehensive and effective diabetes management.

Uses of Gliminift M2

Gliminift M2 is primarily prescribed for:

  • Treatment of Type 2 Diabetes Mellitus
  • Management of uncontrolled blood sugar levels
  • Patients not responding adequately to diet and exercise alone
  • Patients requiring combination anti-diabetic therapy
  • Long-term glycemic control management

This medicine is not indicated for Type 1 diabetes or diabetic ketoacidosis.

Benefits of Gliminift M2

Effective Blood Sugar Control

The dual-action formula helps maintain stable blood glucose levels.

Improved Insulin Sensitivity

Metformin improves the body’s response to insulin.

Reduced Risk of Diabetes Complications

Maintaining optimal blood sugar helps lower the risk of long-term diabetic complications.

Once-Daily Convenience

The prolonged-release formulation offers better patient compliance.

Comprehensive Diabetes Management

The combination targets multiple pathways responsible for elevated blood sugar.

Dosage and Administration

  • Take Gliminift M2 exactly as prescribed by your physician.
  • It is generally recommended to be taken with meals.
  • Swallow the tablet whole with water.
  • Do not crush, chew, or break the prolonged-release tablet.

The dosage may vary depending on:

  • Blood sugar levels
  • Patient age
  • Kidney function
  • Individual treatment response

Always follow your doctor’s recommendations.

Possible Side Effects

Like all medicines, Gliminift M2 may cause some side effects, including:

  • Nausea
  • Vomiting
  • Diarrhea
  • Stomach discomfort
  • Headache
  • Dizziness
  • Weakness
  • Hypoglycemia (low blood sugar)
  • Weight changes

Most side effects are mild and temporary. Consult your healthcare provider if symptoms persist.

Precautions

Before using Gliminift M2, inform your doctor if you have:

  • Kidney disease
  • Liver disease
  • Heart disease
  • Alcohol dependency
  • Pregnancy or breastfeeding status
  • History of hypoglycemia

Regular monitoring of blood glucose and kidney function is recommended during treatment.

Storage Instructions

  • Store below 30°C.
  • Keep in a cool and dry place.
  • Protect from moisture and direct sunlight.
  • Keep out of reach of children.

Why Choose Curavax Pharmaceuticals Pvt. Ltd.?

Curavax Pharmaceuticals Pvt. Ltd. is committed to providing high-quality pharmaceutical products manufactured according to stringent quality standards. Our mission is to deliver safe, effective, and affordable healthcare solutions.

Advantages of Curavax Pharmaceuticals Pvt. Ltd.

  • WHO-GMP quality standards
  • Extensive pharmaceutical product portfolio
  • Reliable manufacturing practices
  • Competitive pricing
  • Strong distribution network
  • Professional customer support
  • Trusted PCD Pharma Franchise opportunities